After getting a cool reception from several drug companies, Bear leveraged an MIT connection into a meeting with scientists from Merck, which agreed to license its mGluR5 drug to Seaside.

FORBES: The Man Behind Biotech's Bold Push For Autism Drugs

MIT's Media Lab is chock-full of cutting-edge tech projects that researchers create, then often license to manufacturers and developers.

ENGADGET: NewsFlash uses high-frequency light to transmit data from iPad to smartphone, we go hands-on (video)